These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 15382621)

  • 21. [Predictors of the efficacy of methods for psychocorrection in patients with irritable bowel syndrome and constipation].
    Aĭvazian TA; Zaĭtsev VP; Pakhomova IV; Gusakova EV
    Vopr Kurortol Fizioter Lech Fiz Kult; 2008; (5):6-8. PubMed ID: 19069796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Common Functional Gastroenterological Disorders Associated With Abdominal Pain.
    Bharucha AE; Chakraborty S; Sletten CD
    Mayo Clin Proc; 2016 Aug; 91(8):1118-32. PubMed ID: 27492916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of irritable bowel syndrome. A case control experience.
    Astegiano M; Pellicano R; Terzi E; Simondi D; Rizzetto M
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):359-63. PubMed ID: 17108865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bloating and distention in irritable bowel syndrome: the role of visceral sensation.
    Agrawal A; Houghton LA; Lea R; Morris J; Reilly B; Whorwell PJ
    Gastroenterology; 2008 Jun; 134(7):1882-9. PubMed ID: 18455167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Meteospazmil for correction of motor disorders in functional colon diseases].
    Agafonova NA; Iakovenko EP; Ivanov AN; Prianishnikova AS; Iakovenko AV
    Eksp Klin Gastroenterol; 2009; (4):101-6. PubMed ID: 19961001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Irritable bowel syndrome: an international study of symptoms in eight countries.
    Gerson CD; Gerson MJ; Awad RA; Chowdhury A; Dancey C; Poitras P; Porcelli P; Sperber A; Wang WA
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):659-67. PubMed ID: 18679069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of a laxative with and without tegaserod in adolescents with constipation predominant irritable bowel syndrome.
    Khoshoo V; Armstead C; Landry L
    Aliment Pharmacol Ther; 2006 Jan; 23(1):191-6. PubMed ID: 16393297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Irritable bowel syndrome: modern concepts and management options.
    Sayuk GS; Gyawali CP
    Am J Med; 2015 Aug; 128(8):817-27. PubMed ID: 25731138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart rate variability is related to pain severity and predominant bowel pattern in women with irritable bowel syndrome.
    Cain KC; Jarrett ME; Burr RL; Hertig VL; Heitkemper MM
    Neurogastroenterol Motil; 2007 Feb; 19(2):110-8. PubMed ID: 17244165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abdominal pain, bloating, and urgency.
    Ferrero S; Abbamonte LH; Valentino R; Ragni N
    Obstet Gynecol; 2005 Jul; 106(1):195; author reply 195. PubMed ID: 15994647
    [No Abstract]   [Full Text] [Related]  

  • 32. Probiotics and functional gastrointestinal disorders in children.
    Vandenplas Y; Benninga M
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S107-9. PubMed ID: 19300120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irritable bowel syndrome in women.
    Roisinblit KC
    J Midwifery Womens Health; 2013; 58(1):15-24; quiz 116-7. PubMed ID: 23279011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacotherapy for functional gastrointestinal disorders in children.
    Saps M; Di Lorenzo C
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S101-3. PubMed ID: 19300118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.
    Chang L; Ameen VZ; Dukes GE; McSorley DJ; Carter EG; Mayer EA
    Am J Gastroenterol; 2005 Jan; 100(1):115-23. PubMed ID: 15654790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stability of irritable bowel syndrome using a Rome II-based classification.
    Williams RE; Black CL; Kim HY; Andrews EB; Mangel AW; Buda JJ; Cook SF
    Aliment Pharmacol Ther; 2006 Jan; 23(1):197-205. PubMed ID: 16393298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical approaches to irritable bowel syndrome.
    Weber FH; McCallum RW
    Lancet; 1992 Dec; 340(8833):1447-52. PubMed ID: 1360569
    [No Abstract]   [Full Text] [Related]  

  • 38. [Irritable bowel treatment].
    Fassov J; Fynne L; Krarup AL
    Ugeskr Laeger; 2016 Aug; 178(35):. PubMed ID: 27592867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Irritable bowel syndrome in adults in primary care: summary of updated NICE guidance.
    Hookway C; Buckner S; Crosland P; Longson D
    BMJ; 2015 Feb; 350():h701. PubMed ID: 25716701
    [No Abstract]   [Full Text] [Related]  

  • 40. Irritable bowel syndrome in women. Exploring diagnoses & treatment options.
    Graef JI
    AWHONN Lifelines; 2003; 7(4):324-30. PubMed ID: 14528589
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.